We are live on
!
Find out more
Federated Hermes Portfolio holdings
AUM
$61.5B
1-Year Est. Return
30.7%
This Fund
S&P 500
This Quarter
Est. Return
+2.58%
1 Year Est. Return
+30.7%
3 Year Est. Return
+96.89%
5 Year Est. Return
+121.97%
10 Year Est. Return
+542.41%
AUM
$25.3B
AUM Growth
–
Cap. Flow
+$25.3B
Cap. Flow
% of AUM
100.27%
Top 10 Holdings %
Top 10 Hldgs %
21.28%
Holding
1,719
New
1,712
Increased
–
Reduced
–
Closed
–
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
AT&T
T
|
+$679M |
| 2 |
ConocoPhillips
COP
|
+$598M |
| 3 |
Verizon
VZ
|
+$596M |
| 4 |
Merck
MRK
|
+$558M |
| 5 |
Johnson & Johnson
JNJ
|
+$540M |
Top Sells
No sells this quarter
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 18.32% |
| 2 | Consumer Staples | 11.36% |
| 3 | Energy | 9.86% |
| 4 | Financials | 9.28% |
| 5 | Industrials | 8.59% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
CIE
26
DELISTED
Cobalt International Energy, Inc
CIE
| $185M | 0.73% |
+465,168
| New | +$188M |
|
27
National Grid
NGG
$79.6B
| $182M | 0.72% |
+3,328,488
| New | +$194M |
|
28
TotalEnergies
TTE
$192B
| $179M | 0.71% |
+3,681,824
| New | +$182M |
|
29
AstraZeneca
AZN
$269B
| $174M | 0.69% |
+3,688,423
| New | +$188M |
|
|
ESRX
30
DELISTED
Express Scripts Holding Company
ESRX
| $167M | 0.66% |
+2,705,245
| New | +$163M |
|
31
LyondellBasell Industries
LYB
$19.6B
| $163M | 0.65% |
+2,460,592
| New | +$155M |
|
32
Gilead Sciences
GILD
$166B
| $159M | 0.63% |
+3,106,267
| New | +$162M |
|
|
RDS.B
33
DELISTED
Royal Dutch Shell PLC ADS Class B
RDS.B
| $159M | 0.63% |
+2,397,619
| New | +$164M |
|
34
Eli Lilly
LLY
$1.08T
| $156M | 0.62% |
+3,185,827
| New | +$173M |
|
35
BP
BP
$112B
| $155M | 0.61% |
+4,531,103
| New | +$158M |
|
36
American Electric Power
AEP
$70.7B
| $152M | 0.6% |
+3,397,574
| New | +$163M |
|
37
GSK
GSK
$106B
| $152M | 0.6% |
+2,425,710
| New | +$154M |
|
|
SLXP
38
DELISTED
SALIX PHARMACEUTICALS LTD DEL
SLXP
| $147M | 0.58% |
+2,220,100
| New | +$127M |
|
39
PepsiCo
PEP
$195B
| $141M | 0.56% |
+1,729,431
| New | +$141M |
|
40
Procter & Gamble
PG
$337B
| $138M | 0.55% |
+1,791,094
| New | +$141M |
|
41
Halliburton
HAL
$26.1B
| $134M | 0.53% |
+3,213,990
| New | +$134M |
|
42
Alkermes
ALKS
$8.2B
| $132M | 0.52% |
+4,619,136
| New | +$135M |
|
|
MRC
43
DELISTED
MRC Global
MRC
| $119M | 0.47% |
+4,324,152
| New | +$128M |
|
|
CBST
44
DELISTED
CUBIST PHARMACEUTICALS INC
CBST
| $118M | 0.47% |
+2,439,000
| New | +$120M |
|
45
Whirlpool
WHR
$2.5B
| $115M | 0.46% |
+1,006,273
| New | +$122M |
|
46
Trane Technologies
TT
$100B
| $112M | 0.44% |
+2,516,665
| New | +$112M |
|
|
POM
47
DELISTED
PEPCO HOLDINGS, INC.
POM
| $111M | 0.44% |
+5,502,471
| New | +$117M |
|
48
Qualcomm
QCOM
$172B
| $107M | 0.43% |
+1,759,533
| New | +$112M |
|
49
CVS Health
CVS
$137B
| $105M | 0.42% |
+1,837,009
| New | +$106M |
|
50
Biogen
BIIB
$30.9B
| $100M | 0.4% |
+466,950
| New | +$99.8M |
|
Similar funds
Federated Hermes's Q2 2013 Portfolio in Review
Q2 2013 is the first quarter with a 13F filing on record for Federated Hermes, which disclosed 1,719 positions worth $25.3B. Its ten largest holdings account for 21% of the portfolio.
Its largest position is AT&T: 24,426,596 shares worth $653M.
By sector, the portfolio is most concentrated in Healthcare at 18% of assets, followed by Consumer Staples and Energy.
- Federated Hermes's largest Q2 2013 buy was AT&T: 24,426,596 shares worth $653M.
- Federated Hermes's ten largest holdings make up 21% of its $25.3B portfolio in Q2 2013.
- Federated Hermes disclosed 1,719 positions in Q2 2013, its first 13F filing on record.
Based on Federated Hermes's 13F filing for Q2 2013, filed 8 Aug 2013.